Cargando…
Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome
Kawasaki disease (KD) is rare in infants less than 3 months of age, and its recurrence is exceptional. Infants with KD are at higher risk of severe clinical presentation, therapy failure, complications and coronary aneurysms (CAAs), and this is the reason they deserve more aggressive therapy and a s...
Autores principales: | Bossi, Grazia, Codazzi, Alessia Claudia, Vinci, Federica, Clerici, Edoardo, Regalbuto, Corrado, Crapanzano, Carmela, Veraldi, Daniele, Moiraghi, Alice, Marseglia, Gian Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139195/ https://www.ncbi.nlm.nih.gov/pubmed/35626849 http://dx.doi.org/10.3390/children9050672 |
Ejemplares similares
-
Successful treatment with Omalizumab of a child affected by Systemic Mastocytosis: clinical and biological implications
por: Bossi, Grazia, et al.
Publicado: (2023) -
Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra
por: Gambacorta, Alessandro, et al.
Publicado: (2020) -
Gynecomastia after euthyroidism restoration in a patient with type 1 diabetes and Graves’ disease
por: Calcaterra, Valeria, et al.
Publicado: (2018) -
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review
por: Ferrara, Giovanna, et al.
Publicado: (2020) -
High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report
por: Shafferman, Ashley, et al.
Publicado: (2014)